NCT02547922anifrolumabsystemic lupus erythematosuslupus nephritisSLETULIP-LN
…tment for moderate to severe SLE.Methods Patients in TULIP-LN ( NCT02547922) received standard therapy plus intravenous anifrolumab or plac…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT02547922 ×
NCT02547922
This funder is selected. Its supporting articles are shown below.